613021

Pfizer Inc — FEI 3005564767

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 18, 2009
Fiscal Year
2009
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Pleasant Prairie, WI (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)